vs

Side-by-side financial comparison of Akamai Technologies (AKAM) and Amneal Pharmaceuticals, Inc. (AMRX). Click either name above to swap in a different company.

Akamai Technologies is the larger business by last-quarter revenue ($1.1B vs $722.5M, roughly 1.5× Amneal Pharmaceuticals, Inc.). Amneal Pharmaceuticals, Inc. runs the higher net margin — 10.8% vs 9.9%, a 0.9% gap on every dollar of revenue. On growth, Amneal Pharmaceuticals, Inc. posted the faster year-over-year revenue change (3.9% vs -2.3%). Over the past eight quarters, Akamai Technologies's revenue compounded faster (4.7% CAGR vs 1.5%).

Akamai Technologies, Inc. provides cloud services for securing, delivering, and optimizing content and business applications over the internet in the United States and internationally. The company offers cloud solutions to keep infrastructure, websites, applications, application programming interfaces, and users safe from various cyberattacks and online threats while enhancing performance. It also provides web and mobile performance solutions to enable dynamic websites and applications; media...

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

AKAM vs AMRX — Head-to-Head

Bigger by revenue
AKAM
AKAM
1.5× larger
AKAM
$1.1B
$722.5M
AMRX
Growing faster (revenue YoY)
AMRX
AMRX
+6.2% gap
AMRX
3.9%
-2.3%
AKAM
Higher net margin
AMRX
AMRX
0.9% more per $
AMRX
10.8%
9.9%
AKAM
Faster 2-yr revenue CAGR
AKAM
AKAM
Annualised
AKAM
4.7%
1.5%
AMRX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AKAM
AKAM
AMRX
AMRX
Revenue
$1.1B
$722.5M
Net Profit
$106.3M
$78.0M
Gross Margin
98.0%
44.3%
Operating Margin
10.7%
19.6%
Net Margin
9.9%
10.8%
Revenue YoY
-2.3%
3.9%
Net Profit YoY
-13.7%
410.5%
EPS (diluted)
$0.71
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AKAM
AKAM
AMRX
AMRX
Q1 26
$1.1B
$722.5M
Q4 25
$1.1B
$814.3M
Q3 25
$1.1B
$784.5M
Q2 25
$1.0B
$724.5M
Q1 25
$1.0B
$695.4M
Q4 24
$1.0B
$730.5M
Q3 24
$1.0B
$702.5M
Q2 24
$979.6M
$701.8M
Net Profit
AKAM
AKAM
AMRX
AMRX
Q1 26
$106.3M
$78.0M
Q4 25
$85.1M
$35.1M
Q3 25
$140.2M
$2.4M
Q2 25
$103.6M
$22.4M
Q1 25
$123.2M
$12.2M
Q4 24
$139.9M
$-31.1M
Q3 24
$57.9M
$-156.0K
Q2 24
$131.7M
$6.0M
Gross Margin
AKAM
AKAM
AMRX
AMRX
Q1 26
98.0%
44.3%
Q4 25
58.7%
36.5%
Q3 25
59.3%
34.9%
Q2 25
59.1%
39.5%
Q1 25
58.7%
36.8%
Q4 24
59.4%
36.0%
Q3 24
59.3%
38.4%
Q2 24
58.9%
35.6%
Operating Margin
AKAM
AKAM
AMRX
AMRX
Q1 26
10.7%
19.6%
Q4 25
8.7%
13.8%
Q3 25
15.7%
9.0%
Q2 25
14.5%
15.4%
Q1 25
15.2%
14.4%
Q4 24
14.5%
10.4%
Q3 24
7.0%
12.6%
Q2 24
15.1%
13.6%
Net Margin
AKAM
AKAM
AMRX
AMRX
Q1 26
9.9%
10.8%
Q4 25
7.8%
4.3%
Q3 25
13.3%
0.3%
Q2 25
9.9%
3.1%
Q1 25
12.1%
1.8%
Q4 24
13.7%
-4.3%
Q3 24
5.8%
-0.0%
Q2 24
13.4%
0.9%
EPS (diluted)
AKAM
AKAM
AMRX
AMRX
Q1 26
$0.71
$0.19
Q4 25
$0.57
$0.10
Q3 25
$0.97
$0.01
Q2 25
$0.71
$0.07
Q1 25
$0.82
$0.04
Q4 24
$0.92
$-0.10
Q3 24
$0.38
$0.00
Q2 24
$0.86
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AKAM
AKAM
AMRX
AMRX
Cash + ST InvestmentsLiquidity on hand
$622.4M
$197.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.9B
Total Assets
$11.6B
$3.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AKAM
AKAM
AMRX
AMRX
Q1 26
$622.4M
$197.7M
Q4 25
$1.2B
$282.0M
Q3 25
$1.1B
$201.2M
Q2 25
$966.6M
$71.5M
Q1 25
$1.3B
$59.2M
Q4 24
$1.6B
$110.6M
Q3 24
$1.7B
$74.0M
Q2 24
$1.6B
$43.8M
Total Debt
AKAM
AKAM
AMRX
AMRX
Q1 26
Q4 25
$2.6B
Q3 25
$2.6B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
AKAM
AKAM
AMRX
AMRX
Q1 26
$4.9B
Q4 25
$5.0B
$-70.8M
Q3 25
$4.7B
$-109.5M
Q2 25
$4.5B
$-112.1M
Q1 25
$4.6B
$-131.7M
Q4 24
$4.9B
$-109.3M
Q3 24
$4.8B
$-93.4M
Q2 24
$4.8B
$-57.5M
Total Assets
AKAM
AKAM
AMRX
AMRX
Q1 26
$11.6B
$3.5B
Q4 25
$11.5B
$3.7B
Q3 25
$10.8B
$3.6B
Q2 25
$10.5B
$3.4B
Q1 25
$10.0B
$3.4B
Q4 24
$10.4B
$3.5B
Q3 24
$10.2B
$3.5B
Q2 24
$10.1B
$3.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AKAM
AKAM
AMRX
AMRX
Operating Cash FlowLast quarter
$312.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
19.2%
Cash ConversionOCF / Net Profit
2.94×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AKAM
AKAM
AMRX
AMRX
Q1 26
$312.5M
Q4 25
$366.6M
$130.3M
Q3 25
$441.8M
$118.5M
Q2 25
$459.1M
$83.8M
Q1 25
$251.2M
$7.4M
Q4 24
$343.8M
$118.1M
Q3 24
$392.5M
$141.8M
Q2 24
$431.0M
$39.7M
Free Cash Flow
AKAM
AKAM
AMRX
AMRX
Q1 26
Q4 25
$234.9M
$108.5M
Q3 25
$329.1M
$106.2M
Q2 25
$313.6M
$61.0M
Q1 25
$133.4M
$-5.8M
Q4 24
$250.9M
$102.9M
Q3 24
$279.7M
$124.8M
Q2 24
$340.0M
$29.0M
FCF Margin
AKAM
AKAM
AMRX
AMRX
Q1 26
Q4 25
21.5%
13.3%
Q3 25
31.2%
13.5%
Q2 25
30.1%
8.4%
Q1 25
13.1%
-0.8%
Q4 24
24.6%
14.1%
Q3 24
27.8%
17.8%
Q2 24
34.7%
4.1%
Capex Intensity
AKAM
AKAM
AMRX
AMRX
Q1 26
19.2%
Q4 25
12.0%
2.7%
Q3 25
10.7%
1.6%
Q2 25
13.9%
3.2%
Q1 25
11.6%
1.9%
Q4 24
9.1%
2.1%
Q3 24
11.2%
2.4%
Q2 24
9.3%
1.5%
Cash Conversion
AKAM
AKAM
AMRX
AMRX
Q1 26
2.94×
Q4 25
4.31×
3.72×
Q3 25
3.15×
50.00×
Q2 25
4.43×
3.74×
Q1 25
2.04×
0.61×
Q4 24
2.46×
Q3 24
6.78×
Q2 24
3.27×
6.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AKAM
AKAM

Security$589.8M55%
Delivery and other cloud applications$389.2M36%
Cloud Infrastructure Services$94.6M9%

AMRX
AMRX

Segment breakdown not available.

Related Comparisons